Reneo Pharmaceuticals Inc (RPHM) Annual Income Statement (USD)
RPHM Quarterly Financials (USD)
Frequently Asked Questions About Reneo Pharmaceuticals Inc (RPHM) Stock
Reneo Pharmaceuticals Inc's (RPHM) last reported annual revenue was USD 0.00.
Reneo Pharmaceuticals Inc's (RPHM) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Reneo Pharmaceuticals Inc's(RPHM) is not profitable as of its last reported annual financials.
The net profit margin for Reneo Pharmaceuticals Inc's(RPHM) from its laster reported year is N/A
The return on equity (ROE) for Reneo Pharmaceuticals Inc's(RPHM) from its last reported annual financials is : -82.07%
The return on assets (ROA) for Reneo Pharmaceuticals Inc's(RPHM) from its last reported annual financials is : -47.77%
The return on invested capital (ROIC) for Reneo Pharmaceuticals Inc's(RPHM) from its last reported annual financials is : -88.08%
The Debt to Equity ratio for Reneo Pharmaceuticals Inc's(RPHM) from its last reported annual financials is : 0.00%
The dividend yield for Reneo Pharmaceuticals Inc's(RPHM) from its laster reported year is 0.00%
Reneo Pharmaceuticals Inc's(RPHM) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RPHM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
